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SUPPLEMENTARY TABLES 
 
Table S1 (Related to Figure 2B). GSEA results.  
Results of GSEA on RNA sequencing from tumor-associated neutrophils (TAN) 
derived from mice that were trained for 7 days with β-glucan or injected with PBS as 
control and were then inoculated with B16-F10 melanoma cells for 14 days, using a 
gene set of 92 genes, implicated as playing a role in the functionality of TAN-1 
(derived from Shaul et al., 2016, specifically Table S4 therein; as described in the 
STAR methods). 86 genes out of the 92 gene set are expressed in our study and their 
position within our ranked list is shown. In addition, RANK METRIC SCORE refers 
to score used to position the gene in the ranked list, RUNNING ES refers to the 
enrichment score at this point in the ranked list of genes, and CORE ENRICHMENT 
describes whether the gene contributed to the leading-edge subset within the gene-set 
(i.e. the subset of genes that contributes most to the enrichment result). 
 
 
Table S2 (Related to Figure 2D). GSEA results. 
Results of GSEA on RNA sequencing from TAN derived from mice that were trained 
for 7 days with β-glucan or injected with PBS as control and were then inoculated 
with B16-F10 melanoma cells for 14 days, using the MSigDB Hallmark Gene Set. 
NAME is the gene set name; SIZE is the number of genes in the gene set after 
filtering out those genes not in the expression dataset; ES is the enrichment score for 
the gene set; NES is the normalized enrichment score that accounts for size 
differences in gene sets; NOM p-val is the nominal p-value of ES significance based 
on permutation test; FDR q-val is the False Discovery Rate; FWER p-val is the 
family-wise error rate; RANK AT MAX is the position in the ranked list at which the 
maximum running enrichment score occurred. 
 
 
Table S3 (Related to Figure 4). The neutrophil bias of GMP upon -glucan-
induced trained immunity. 
WT mice were treated with β-glucan or PBS and after 7 days BM GMP (Lin—c-
Kit+Sca1—CD16/32+CD34+) were sorted and RNA sequencing analysis was 
performed. The neutrophil bias of GMP was analyzed based on GSEA using the 
MSigDB Immunologic Signatures Gene Set. Datasets that include genes that are 
upregulated in neutrophils compared to other cell populations are shown in green and 
datasets with genes downregulated in neutrophils compared to other myeloid cell 
populations are shown in blue. Level of statistical significance was set at FDR = 0.05.  
NAME is the gene set name; SIZE is the number of genes in the gene set after 
filtering out those genes not in the expression dataset; ES is the enrichment score for 
the gene set; NES is the normalized enrichment score that accounts for size 
differences in gene sets; NOM p-val is the nominal p-value of ES significance based 
on permutation test; FDR q-val is the False Discovery Rate; logFDR is the log value 
of FDR; FWER p-val is the family-wise error rate; RANK AT MAX is the position in 
the ranked list at which the maximum running enrichment score occurred. 
 
 
Table S4 (Related to Figure 4G, H). GSEA results 
Results of GSEA on RNA sequencing from GMP derived from mice that were trained 
for 7 days with β-glucan or injected with PBS as control using the MSigDB Hallmark 
Gene Set. NAME is the gene set name; SIZE is the number of genes in the gene set 
after filtering out those genes not in the expression dataset; ES is the enrichment score 
for the gene set; NES is the normalized enrichment score that accounts for size 
differences in gene sets; NOM p-val is the nominal p-value of ES significance based 
on permutation test; FDR q-val is the False Discovery Rate; FWER p-val is the 
family-wise error rate; RANK AT MAX is the position in the ranked list at which the 
maximum running enrichment score occurred. 
 
 
Table S5 (Related to STAR Methods). Gene-specific primers for the ‘trained 
TAN1-like signature’ 
Gene-specific primers for the ‘trained TAN1-like signature’ used for quantitative real-
time PCR analysis. The ‘trained TAN1-like signature’ is defined in ‘STAR Methods’ 














1 ENSMUSG00000020440 15 6.721 0.0686 Yes
2 ENSMUSG00000064373 44 5.321 0.1216 Yes
3 ENSMUSG00000021361 90 4.092 0.1604 Yes
4 ENSMUSG00000063856 105 3.820 0.1990 Yes
5 ENSMUSG00000036887 136 3.528 0.2332 Yes
6 ENSMUSG00000040212 163 3.222 0.2646 Yes
7 ENSMUSG00000023078 177 3.104 0.2957 Yes
8 ENSMUSG00000040950 179 3.078 0.3276 Yes
9 ENSMUSG00000024679 180 3.069 0.3595 Yes
10 ENSMUSG00000024570 243 2.703 0.3825 Yes
11 ENSMUSG00000024965 268 2.607 0.4077 Yes
12 ENSMUSG00000073421 322 2.446 0.4288 Yes
13 ENSMUSG00000036896 358 2.363 0.4505 Yes
14 ENSMUSG00000002741 443 2.079 0.4653 Yes
15 ENSMUSG00000030744 516 1.883 0.4790 Yes
16 ENSMUSG00000069516 519 1.878 0.4984 Yes
17 ENSMUSG00000032436 585 1.778 0.5116 Yes
18 ENSMUSG00000026728 681 1.605 0.5206 Yes
19 ENSMUSG00000031708 706 1.569 0.5349 Yes
20 ENSMUSG00000044533 809 1.442 0.5417 Yes
21 ENSMUSG00000002957 928 1.346 0.5461 Yes
22 ENSMUSG00000021190 998 1.291 0.5539 Yes
23 ENSMUSG00000002981 1004 1.284 0.5669 Yes
24 ENSMUSG00000027466 1029 1.249 0.5779 Yes
25 ENSMUSG00000057191 1082 1.201 0.5862 Yes
26 ENSMUSG00000061477 1100 1.182 0.5971 Yes
27 ENSMUSG00000028063 1221 1.078 0.5985 Yes
28 ENSMUSG00000030707 1253 1.053 0.6070 Yes
29 ENSMUSG00000030802 1322 1.008 0.6119 Yes
30 ENSMUSG00000032369 1350 0.987 0.6200 Yes
31 ENSMUSG00000060601 1477 0.921 0.6194 Yes
32 ENSMUSG00000021094 1520 0.883 0.6252 Yes
33 ENSMUSG00000056076 1590 0.851 0.6284 Yes
34 ENSMUSG00000035199 1656 0.818 0.6317 Yes
35 ENSMUSG00000021917 1666 0.814 0.6394 Yes
36 ENSMUSG00000020432 1671 0.809 0.6475 Yes
37 ENSMUSG00000063316 1676 0.808 0.6555 Yes
38 ENSMUSG00000036908 1678 0.806 0.6638 Yes
39 ENSMUSG00000037370 1709 0.790 0.6696 Yes
40 ENSMUSG00000018927 2005 0.680 0.6528 No
41 ENSMUSG00000026750 2219 0.594 0.6418 No
42 ENSMUSG00000003032 2386 0.536 0.6339 No
43 ENSMUSG00000033220 2519 0.492 0.6283 No
44 ENSMUSG00000026177 2726 0.439 0.6163 No
45 ENSMUSG00000031805 2735 0.438 0.6202 No
46 ENSMUSG00000001056 2862 0.409 0.6142 No
47 ENSMUSG00000029470 2930 0.390 0.6129 No
48 ENSMUSG00000034786 3142 0.337 0.5993 No
49 ENSMUSG00000007564 3340 0.293 0.5864 No
50 ENSMUSG00000016319 3363 0.287 0.5876 No
51 ENSMUSG00000051695 3574 0.249 0.5732 No
52 ENSMUSG00000035493 3588 0.247 0.5747 No
53 ENSMUSG00000089832 3641 0.239 0.5730 No
54 ENSMUSG00000060743 3721 0.227 0.5690 No
55 ENSMUSG00000067212 3795 0.214 0.5653 No
56 ENSMUSG00000075705 3930 0.193 0.5565 No
57 ENSMUSG00000023067 4147 0.163 0.5407 No
58 ENSMUSG00000029528 4349 0.140 0.5259 No
59 ENSMUSG00000025491 4386 0.136 0.5244 No
60 ENSMUSG00000017057 4628 0.112 0.5061 No
61 ENSMUSG00000022831 4707 0.103 0.5008 No
62 ENSMUSG00000015714 4933 0.078 0.4834 No
63 ENSMUSG00000004934 4989 0.072 0.4797 No
64 ENSMUSG00000022090 5048 0.065 0.4757 No
65 ENSMUSG00000037731 5197 0.046 0.4642 No
66 ENSMUSG00000026158 6669 0.000 0.3453 No
67 ENSMUSG00000032324 7306 -0.038 0.2943 No
68 ENSMUSG00000055413 7313 -0.039 0.2942 No
69 ENSMUSG00000025351 7499 -0.058 0.2799 No
70 ENSMUSG00000029723 7639 -0.074 0.2694 No
71 ENSMUSG00000029621 8670 -0.191 0.1881 No
72 ENSMUSG00000036620 9418 -0.316 0.1310 No
73 ENSMUSG00000027333 9443 -0.319 0.1324 No
74 ENSMUSG00000028494 9488 -0.327 0.1322 No
75 ENSMUSG00000029064 9644 -0.362 0.1234 No
76 ENSMUSG00000052423 9667 -0.368 0.1255 No
77 ENSMUSG00000021453 9761 -0.394 0.1220 No
78 ENSMUSG00000021134 9965 -0.446 0.1103 No
79 ENSMUSG00000038467 9998 -0.454 0.1124 No
80 ENSMUSG00000021998 10131 -0.490 0.1068 No
81 ENSMUSG00000034855 10876 -0.797 0.0549 No
82 ENSMUSG00000054808 10919 -0.823 0.0601 No
83 ENSMUSG00000028249 10997 -0.867 0.0629 No
84 ENSMUSG00000020946 11396 -1.222 0.0434 No
85 ENSMUSG00000031207 11546 -1.427 0.0461 No
86 ENSMUSG00000021196 11986 -2.618 0.0378 No
Table S2
NAME
1 HALLMARK_XENOBIOTIC_METABOLISM 153 0.57 1,89 0.000 0.000 0.000 2585 tags=36%, list=21%, signal=45%
2 HALLMARK_COAGULATION 103 0.57 1,74 0.000 0.006 0.006 1973 tags=34%, list=16%, signal=40%
3 HALLMARK_COMPLEMENT 150 0.51 1,66 0.000 0.015 0.021 1973 tags=28%, list=16%, signal=33%




143 0.46 1,50 0.004 0.055 0.129 2024 tags=29%, list=16%, signal=34%




42 0.54 1,45 0.044 0.061 0.202 2638 tags=40%, list=21%, signal=51%
8 HALLMARK_BILE_ACID_METABOLISM 83 0.48 1,44 0.018 0.056 0.212 2170 tags=35%, list=17%, signal=42%
9 HALLMARK_OXIDATIVE_PHOSPHORYLATION 188 0.41 1,41 0.005 0.069 0.269 2565 tags=38%, list=21%, signal=47%
10 HALLMARK_FATTY_ACID_METABOLISM 126 0.43 1,38 0.022 0.081 0.334 1120 tags=17%, list=9%, signal=18%
11 HALLMARK_UV_RESPONSE_UP 115 0.37 1,19 0.109 0.339 0.865 709 tags=12%, list=6%, signal=13%
12 HALLMARK_PEROXISOME 79 0.40 1,17 0.164 0.345 0.891 2240 tags=33%, list=18%, signal=40%
13 HALLMARK_KRAS_SIGNALING_UP 140 0.34 1,11 0.212 0.483 0.970 2535 tags=28%, list=20%, signal=35%
14 HALLMARK_INFLAMMATORY_RESPONSE 163 0.33 1,10 0.202 0.471 0.977 2200 tags=21%, list=18%, signal=26%
15 HALLMARK_INTERFERON_GAMMA_RESPONSE 174 0.32 1,10 0.190 0.450 0.978 1924 tags=24%, list=15%, signal=27%
16 HALLMARK_APOPTOSIS 144 0.33 1,08 0.227 0.476 0.986 1654 tags=18%, list=13%, signal=21%
17 HALLMARK_ADIPOGENESIS 183 0.30 1.00 0.443 0.688 0.998 2613 tags=32%, list=21%, signal=40%
18 HALLMARK_PI3K_AKT_MTOR_SIGNALING 92 0.33 0.98 0.485 0.726 0.999 1175 tags=15%, list=9%, signal=17%
19 HALLMARK_MTORC1_SIGNALING 190 0.29 0.96 0.593 0.771 1.000 1253 tags=12%, list=10%, signal=13%
20 HALLMARK_IL2_STAT5_SIGNALING 170 0.29 0.95 0.598 0.771 1.000 1134 tags=12%, list=9%, signal=13%
21 HALLMARK_MYOGENESIS 128 0.28 0.92 0.717 0.848 1.000 1441 tags=12%, list=12%, signal=13%
22 HALLMARK_MYC_TARGETS_V1 195 0.27 0.91 0.743 0.827 1.000 1632 tags=17%, list=13%, signal=19%
23 HALLMARK_IL6_JAK_STAT3_SIGNALING 76 0.30 0.89 0.653 0.851 1.000 1977 tags=18%, list=16%, signal=22%
24 HALLMARK_P53_PATHWAY 175 0.26 0.88 0.848 0.845 1.000 2720 tags=23%, list=22%, signal=29%
25 HALLMARK_APICAL_JUNCTION 130 0.26 0.83 0.917 0.944 1.000 2335 tags=22%, list=19%, signal=27%
26 HALLMARK_HEDGEHOG_SIGNALING 24 0.34 0.80 0.764 0.943 1.000 832 tags=13%, list=7%, signal=13%
27 HALLMARK_NOTCH_SIGNALING 26 0.33 0.79 0.799 0.919 1.000 762 tags=8%, list=6%, signal=8%
FDR q-val FWER p-val
RANK AT 
MAX
LEADING EDGESIZE ES NES NOM p-val
Table S3
NAME SIZE ES NES NOM p‐val FDR q‐val logFDR FWER  RANK  LEADING EDGE
p‐val AT MAX
GSE3982_NEUTROPHIL_VS_BASOPHIL_UP 127 0.18792799 2.4936059 0.0 0,002506787 ‐2,6009 0.706 4141 tags=54%, list=36%, signal=84%
GSE27786_NEUTROPHIL_VS_MONO_MAC_UP 147 0.17262954 2.4513268 0.0 0,00330879 ‐2,4803 0.819 4488 tags=56%, list=39%, signal=90%
GSE22886_NEUTROPHIL_VS_MONOCYTE_DN 186 ‐0.21431348 ‐3.4768302 0.0 0,0000001 ‐7 0.0 3476 tags=51%, list=30%, signal=72%
GSE22886_NEUTROPHIL_VS_DC_DN 187 ‐0.19650963 ‐3.0743666 0.0 1,79E‐05 ‐4,7464 0.008 4701 tags=60%, list=41%, signal=99%
GSE27786_NEUTROPHIL_VS_MONO_MAC_DN 163 ‐0.13489847 ‐2.0292807 0.0039525 0,02150858 ‐1,6674 1.0 6351 tags=68%, list=55%, signal=149%
GSE3982_NEUTROPHIL_VS_BASOPHIL_DN 164 ‐0.13247892 ‐1.9812163 0.0057361 0,027381597 ‐1,5625 1.0 6260 tags=67%, list=54%, signal=144%
Table S4
NAME SIZE ES NES NOM p‐val FDR q‐val FWER  RANK  LEADING EDGE
p‐val AT MAX
HALLMARK_ADIPOGENESIS 185 ‐0.33846906 ‐1.3614275 0.013333334 0.28227615 1.0 4268 tags=39%, list=21%, signal=49%
HALLMARK_COAGULATION 100 ‐0.33541805 ‐1.2790787 0.052173913 0.34569374 1.0 1235 tags=17%, list=6%, signal=18%
HALLMARK_DNA_REPAIR 137 ‐0.34788033 ‐1.3801625 0.014851485 0.26497552 1.0 5882 tags=47%, list=29%, signal=66%
HALLMARK_E2F_TARGETS 194 ‐0.31480807 ‐1.3173583 0.0062111802 0.3153329 1.0 3084 tags=28%, list=15%, signal=33%
HALLMARK_FATTY_ACID_METABOLISM 135 ‐0.4787959 ‐1.9237534 0.0 0.004593605 0.644 3068 tags=32%, list=15%, signal=37%
HALLMARK_GLYCOLYSIS 179 ‐0.26821175 ‐1.0679168 0.270073 0.552309 1.0 3069 tags=23%, list=15%, signal=27%
HALLMARK_HEME_METABOLISM 182 ‐0.4612496 ‐1.8512348 0.0 0.011261245 0.962 3668 tags=43%, list=18%, signal=52%
HALLMARK_MYC_TARGETS_V1 191 ‐0.5460221 ‐2.215301 0.0 2.1171085E‐5 0.002 4388 tags=50%, list=21%, signal=63%
HALLMARK_MYC_TARGETS_V2 56 ‐0.2756289 ‐0.93721586 0.5738832 0.7502626 1.0 5078 tags=32%, list=25%, signal=43%
HALLMARK_OXIDATIVE_PHOSPHORYLATION 192 ‐0.6128583 ‐2.4825552 0.0 0.0 0.0 3337 tags=48%, list=16%, signal=57%
HALLMARK_PANCREAS_BETA_CELLS 16 ‐0.37138817 ‐0.9443386 0.5298507 0.738289 1.0 3887 tags=44%, list=19%, signal=54%
HALLMARK_PEROXISOME 87 ‐0.32129171 ‐1.1875292 0.104417674 0.43081608 1.0 3737 tags=25%, list=18%, signal=31%
HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY 45 ‐0.3314567 ‐1.0733126 0.3138686 0.5458442 1.0 1475 tags=22%, list=7%, signal=24%
HALLMARK_SPERMATOGENESIS 95 ‐0.3639183 ‐1.3378547 0.034042552 0.30096272 1.0 2540 tags=19%, list=12%, signal=22%
HALLMARK_XENOBIOTIC_METABOLISM 156 ‐0.34734932 ‐1.3840812 0.005319149 0.26299122 1.0 3148 tags=27%, list=15%, signal=32%
HALLMARK_ALLOGRAFT_REJECTION 170 0.46404052 1.5719068 0.0023501762 0.052239303 1.0 2577 tags=29%, list=13%, signal=33%
HALLMARK_ANDROGEN_RESPONSE 89 0.39515847 1.2371061 0.12663186 0.27786115 1.0 4638 tags=36%, list=23%, signal=46%
HALLMARK_ANGIOGENESIS 30 0.4034587 1.0658443 0.3589365 0.5110081 1.0 1217 tags=23%, list=6%, signal=25%
HALLMARK_APICAL_JUNCTION 154 0.3940256 1.3250257 0.032104637 0.19279501 1.0 3326 tags=24%, list=16%, signal=28%
HALLMARK_APICAL_SURFACE 34 0.39776358 1.0732794 0.35548687 0.50010306 1.0 3977 tags=38%, list=19%, signal=47%
HALLMARK_APOPTOSIS 142 0.37509593 1.2475381 0.0964591 0.26687083 1.0 3111 tags=27%, list=15%, signal=32%
HALLMARK_BILE_ACID_METABOLISM 90 0.28031233 0.895026 0.65653896 0.7631104 1.0 3121 tags=19%, list=15%, signal=22%
HALLMARK_CHOLESTEROL_HOMEOSTASIS 65 0.3066085 0.93213403 0.59172416 0.7101496 1.0 3408 tags=23%, list=17%, signal=28%
HALLMARK_COMPLEMENT 162 0.56313586 1.879213 0.0 0.0022028668 0.573 3401 tags=38%, list=17%, signal=45%
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION 162 0.33245185 1.1169387 0.24357405 0.43610907 1.0 2355 tags=16%, list=11%, signal=18%
HALLMARK_ESTROGEN_RESPONSE_EARLY 165 0.3664692 1.245726 0.082825825 0.26891556 1.0 4005 tags=28%, list=19%, signal=35%
HALLMARK_ESTROGEN_RESPONSE_LATE 158 0.3027445 1.0176535 0.41428572 0.58285004 1.0 2845 tags=21%, list=14%, signal=24%
HALLMARK_G2M_CHECKPOINT 190 0.31091806 1.0591061 0.3479769 0.52160436 1.0 4276 tags=31%, list=21%, signal=39%
HALLMARK_HEDGEHOG_SIGNALING 28 0.570338 1.4751666 0.03598201 0.09293582 1.0 4459 tags=57%, list=22%, signal=73%
HALLMARK_HYPOXIA 172 0.4015272 1.3718623 0.020190023 0.1560477 1.0 3392 tags=27%, list=16%, signal=32%
HALLMARK_IL2_STAT5_SIGNALING 186 0.39008537 1.3308102 0.036599763 0.18805379 1.0 3324 tags=30%, list=16%, signal=36%
HALLMARK_IL6_JAK_STAT3_SIGNALING 76 0.62220806 1.9157144 0.0 0.0012145527 0.326 1563 tags=38%, list=8%, signal=41%
HALLMARK_INFLAMMATORY_RESPONSE 171 0.6786922 2.2992964 0.0 0.0 0.0 3358 tags=50%, list=16%, signal=60%
HALLMARK_INTERFERON_ALPHA_RESPONSE 87 0.7168267 2.2577653 0.0 0.0 0.0 2231 tags=44%, list=11%, signal=49%
HALLMARK_INTERFERON_GAMMA_RESPONSE 179 0.6370029 2.1780353 0.0 0.0 0.0 2577 tags=41%, list=13%, signal=46%
HALLMARK_KRAS_SIGNALING_DN 99 0.36303 1.153687 0.21501273 0.3836147 1.0 3617 tags=26%, list=18%, signal=32%
HALLMARK_KRAS_SIGNALING_UP 156 0.3227955 1.0742397 0.32555282 0.49895805 1.0 3324 tags=26%, list=16%, signal=30%
HALLMARK_MITOTIC_SPINDLE 197 0.5210862 1.8103101 0.0 0.0057318024 0.976 4044 tags=38%, list=20%, signal=47%
HALLMARK_MTORC1_SIGNALING 194 0.29150614 1.0057975 0.4749709 0.60129726 1.0 3822 tags=26%, list=19%, signal=32%
HALLMARK_MYOGENESIS 148 0.23314323 0.780032 0.8951132 0.90023285 1.0 3399 tags=20%, list=16%, signal=23%
HALLMARK_NOTCH_SIGNALING 30 0.41829374 1.1076216 0.33333334 0.4495052 1.0 2864 tags=27%, list=14%, signal=31%
HALLMARK_P53_PATHWAY 185 0.39183876 1.3434826 0.025974026 0.17812084 1.0 2544 tags=23%, list=12%, signal=26%
HALLMARK_PI3K_AKT_MTOR_SIGNALING 95 0.51282907 1.6282574 0.0025839794 0.035768677 1.0 2160 tags=23%, list=10%, signal=26%
HALLMARK_PROTEIN_SECRETION 92 0.44095328 1.3757209 0.051587302 0.15286866 1.0 3282 tags=26%, list=16%, signal=31%
HALLMARK_TGF_BETA_SIGNALING 50 0.37458792 1.0818352 0.33994335 0.48809466 1.0 3144 tags=28%, list=15%, signal=33%
HALLMARK_TNFA_SIGNALING_VIA_NFKB 183 0.5215684 1.7845715 0.0 0.008045328 0.998 3144 tags=36%, list=15%, signal=42%
HALLMARK_UNFOLDED_PROTEIN_RESPONSE 105 0.37609214 1.2050011 0.14133333 0.3157383 1.0 3372 tags=24%, list=16%, signal=28%
HALLMARK_UV_RESPONSE_DN 131 0.4610755 1.5076544 0.0024271845 0.07844182 1.0 2046 tags=22%, list=10%, signal=24%
HALLMARK_UV_RESPONSE_UP 132 0.32200328 1.0633616 0.33736396 0.51492196 1.0 4348 tags=30%, list=21%, signal=37%
HALLMARK_WNT_BETA_CATENIN_SIGNALING 37 0.42813328 1.170017 0.2392638 0.3607959 1.0 2198 tags=22%, list=11%, signal=24%
Table S5
Oligonucleotides
FW Arf5 5'-ATGCGGCTGGCAAGACTAC-3'
RV Arf5 5'-ACAGAGGCCGAATCTTATCCT-3'
FW Selenop 5'-AGCTCTGCTTGTTACAAAGCC-3'
RV Selenop 5'-CAGGTCTTCCAATCTGGATGC-3'
FW C1qa 5'-AAAGGCAATCCAGGCAATATCA-3'
RV C1qa 5'-TGGTTCTGGTATGGACTCTCC-3'
FW Cxcl13 5'-GGCCACGGTATTCTGGAAGC-3'
RV Cxcl13 5'-GGGCGTAACTTGAATCCGATCTA-3'
FW Mgl2 5'-TTAGCCAATGTGCTTAGCTGG-3'
RV Mgl2 5'-GGCCTCCAATTCTTGAAACCT-3'
FW Ms4a6d 5'-TTCCATCCTGTTAGAATCTGGCT-3'
RV Ms4a6d 5'-GTGAACCAAAGGCTTAGTCATCT-3'
FW Rbfa 5'-GCCATCCAAGCATGAGTTCCT-3'
RV Rbfa 5'-AGCAGTTCCGTCAATGATTTGTA-3'
FW H2-Ab1 5'-TGAACAGCCCAATGTCGTCAT-3'
RV H2-Ab1 5'-CAGCGCACTTTGATCTTGGC-3'
FW C1qc 5'-AGAAGCACCAGTCGGTATTCA-3'
RV C1qc 5'-TGCGATGTGTAGTAGACGAAGTA-3'
FW Ykt6 5'-AGTCAACTGATTGTGGAACGC-3'
RV Ykt6 5'-TCTGGAAGGGTATTCGCTGTC-3'
FW Tmem14c 5'-CAGTGGCCCATTGATGCCTT-3'
RV Tmem14c 5'-GACGGCACACTACCTGCTT-3'
FW Gpx1 5'-AGTCCACCGTGTATGCCTTCT-3'
RV Gpx1 5'-GAGACGCGACATTCTCAATGA-3'
FW Emp3 5'-TGGTGCTGTCTCTCATCCTCT-3'
RV Emp3 5'-CGAAGCAGTAACCGAAGCTG-3'
FW Fermt3 5'-ATGGCGGGTATGAAGACAGC-3'
RV Fermt3 5'-CACCAATGTGCGACTCCCC-3'
FW Lyz2 5'-ATGGAATGGCTGGCTACTATGG-3'
RV Lyz2 5'-ACCAGTATCGGCTATTGATCTGA-3'
FW Cmtm7 5'-TCCAAGAGTTACAACCAGAGTGG-3'
RV Cmtm7 5'-CACAAGCTCGCTAGGCAGAG-3'
FW Vim 5'-CGGCTGCGAGAGAAATTGC-3'
RV Vim 5'-CCACTTTCCGTTCAAGGTCAAG-3'
FW Tecr 5'-AAGCACTACGAGGTGGAGATT-3'
RV Tecr 5'-TGAGGCTCTACCTTGTCCAGG-3'
FW Ap2a2 5'-ACAGATACACGGAAAAGCAGATT-3'
RV Ap2a2 5'-ACCCATAAACGTAGGATTGCG-3'
FW Rps3 5'-ATGGCGGTGCAGATTTCCAA-3'
RV Rps3 5'-GTAACTCGGACTTCAACTCCAG-3'
